United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - gadoversetamide (unii: rlm74t3z9d) (gadolinium cation (3+) - unii:azv954tz9n) - gadoversetamide 0.5 mmol in 1 ml

European Union - English - EMA (European Medicines Agency)

mallinckrodt deutschland gmbh - gadoversetamide - magnetic resonance imaging - contrast media - this medicinal product is for diagnostic use only.optimark is indicated for use with magnetic resonance imaging (mri) of the central nervous system (cns) and liver. it provides contrast enhancement and facilitates visualisation and helps with the characterisation of focal lesions and abnormal structures in the cns and liver in patients with known or highly suspected pathology.

Canada - English - Health Canada

liebel-flarsheim canada inc - gadoversetamide - solution - 330.9mg - gadoversetamide 330.9mg - other diagnostic agents

Canada - English - Health Canada

liebel-flarsheim canada inc - gadoversetamide - solution - 330.9mg - gadoversetamide 330.9mg - other diagnostic agents

Canada - English - Health Canada

liebel-flarsheim canada inc - gadoversetamide - solution - 330.9mg - gadoversetamide 330.9mg - other diagnostic agents

Canada - English - Health Canada

liebel-flarsheim canada inc - gadoversetamide - solution - 330.9mg - gadoversetamide 330.9mg - other diagnostic agents

Canada - English - Health Canada

liebel-flarsheim canada inc - gadoversetamide - solution - 330.9mg - gadoversetamide 330.9mg - other diagnostic agents

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - gadoversetamide - injection - 0.5 mmol/ml

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - gadoversetamide - injection - 0.5 mmol/ml

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - gadoversetamide - injection - 0.5 mmol/ml